Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

C4 Therapeutics Q2 2024 GAAP EPS $(0.26) Beats $(0.37) Estimate, Sales $12.01M Beat $4.78M Estimate, Cash, Cash Equivalents and Marketable Securities of $295.7M As Of June 30, Expected to Provide Runway into 2027

Author: Benzinga Newsdesk | August 01, 2024 07:54am

Posted In: CCCC